tiprankstipranks
Trending News
More News >

Jon Stonehouse Insider Profile

11 Followers
Jon Stonehouse, CEO, Director at BioCryst, holds 1.47M shares in BioCryst (Ticker: BCRX), holds 0.00 shares in Metsera, Inc. (Ticker: MTSR), holds 204.09K shares in Bellicum Pharmaceuticals (Ticker: BLCM).
tipranks
Jon Stonehouse

Jon Stonehouse
BioCryst (BCRX)
CEO, Director

Ranked #20,005 out of 105,219 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+43.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$11M
100.00%
A breakdown of Jon Stonehouse's holdings

Insider Roles

BioCryst
(BCRX)
CEO, Director
Roles that Jon Stonehouse holds in companies

Most Profitable Insider Trade

Stock:
BioCryst
(BCRX)
Rating:Informative Buy
Date:Nov 18, 2019 - Nov 18, 2020
Return:+151.70%
The most profitable trade made by Jon Stonehouse

Jon Stonehouse's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BioCryst
Dec 19, 2025
CEO, Director
Uninformative Buy
$10.86M
MTSR
Metsera, Inc.
Nov 13, 2025
Uninformative Sell
$0.00
BLCM
Bellicum Pharmaceuticals
Nov 13, 2018
Informative Buy
45.60K
$15.10K
List of latest transactions for each holding click on a transaction to see Jon Stonehouse's performance on stock

Jon Stonehouse insider profile FAQ

What is the percentage of profitable transactions made by Jon Stonehouse?
The percentage of profitable transactions made by Jon Stonehouse is 67%.
    What is the average return per transaction made by Jon Stonehouse?
    The average return per transaction made by Jon Stonehouse is 43.90%.
      What stocks does Jon Stonehouse hold?
      Jon Stonehouse holds: BCRX, MTSR, BLCM stocks.
        What was Jon Stonehouse’s latest transaction?
        Jon Stonehouse latest transaction was an Uninformative Buy of ―.
          What was Jon Stonehouse's most profitable transaction?
          Jon Stonehouse’s most profitable transaction was an Informative Buy of BCRX stock on November 18, 2019. The return on the trade was 151.70%.
            What is Jon Stonehouse's role in BioCryst?
            Jon Stonehouse's role in BioCryst is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.